Live Webinar: Race for a COVID-19 vaccine
This Thursday, July 30, 2020 at 6 p.m. EDT, join us for a 1-hour live webinar as experts in infectious disease, virology, and vaccinology break down the top vaccine candidates, key findings from the latest clinical trials, and discuss ways to overcome the logistical hurdles of a vaccine rollout amid a global pandemic.
Vaccine developments to prevent SARS-CoV-2 are well underway as many candidates are entering phase 3 trials and major government investments for the first 100 million doses are starting to pour in. Case counts continue to climb, making this one of the most important public health challenges this country has ever faced.
This Thursday, July 30, 2020 at 6 p.m. EDT, join us for a 1-hour live webinar as experts in infectious disease, virology, and vaccinology break down the top vaccine candidates, key findings from the latest clinical trials, and discuss ways to overcome the logistical hurdles of a vaccine rollout amidst a global pandemic.
Register for and learn more about the top minds you will hear from in this groundbreaking virtual event here.
Following the live webinar, Contemporary OB/GYN will publish an article detailing the vaccinations and their impact on pregnant women, women who are breastfeeding, and more as it pertains to ob/gyns.
After tuning in, contact us on Twitter and Facebook to let us know what you are interested in learning more about as it pertains to the vaccinations and your obstetric and gynecologic practice.
S4E1: New RNA platform can predict pregnancy complications
February 11th 2022In this episode of Pap Talk, Contemporary OB/GYN® sat down with Maneesh Jain, CEO of Mirvie, and Michal Elovitz, MD, chief medical advisor at Mirvie, a new RNA platform that is able to predict pregnancy complications by revealing the biology of each pregnancy. They discussed recently published data regarding the platform's ability to predict preeclampsia and preterm birth.
Listen
Contemporary OB/GYN Senior Editor Angie DeRosa gets insight on the current state of COVID-19 from Christina Han, MD, division director of maternal-fetal medicine at the University of California, Los Angeles, and member of its COVID-19 task force. Han is an active member of the Society for Maternal-Fetal Medicine and discusses the issues on behalf of SMFM.
Listen
